An oral composition capable of identifying a condition within the oral cavity by causing a visual contrast between the condition and the hard and soft tissues of the oral cavity has at least one disclosing agent. The disclosing agent can fluoresce in order to highlight conditions within the oral cavity.

The inventors have investigated a fluorescent substance being safe and having a high color developing property, and it is one of objects of the present disclosure to obtain an inorganic red fluorescent substance consisting of an element which exerts no bad influence upon human bodies.

A cosmetic containing inorganic particles consisting of a compound represented by a general formula:

Ca.sub.xAl.sub.yO.sub.(2x+3y+4z)/2:Mn.sup.4+.sub.z

wherein 0.1<x<1.05, 11.9<y12, and 0.0005<z<0.1.

The present disclosure provides biophotonic topical compositions and methods useful in phototherapy. In particular, the biophotonic topical compositions of the present disclosure are substantially resistant to leaching such that very low amounts of chromophore(s) present in the biophotonic composition leach out of the composition. The biophotonic compositions and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various skin disorders.

Optically-activated systems and methods for reducing the appearance of dark under eye circles are provided. The systems comprise a complex of a fluorescent compound and a substrate for the fluorescent compound which are affixed to one another by covalent bonding, hydrogen bonding, Van der Waals forces, or a combination thereof. After absorption of ambient light, the fluorescent compound in the complex re-emits visible light of longer wavelength. The re-emitted light provides an illuminating radiant effect and is particularly useful in improving the appearance of skin imperfections.

There is provided a novel production method of a powder cosmetic containing a UV wavelength conversion substance including a slurry step, and a powder cosmetic produced by this method.

The present disclosure provides topical biophotonic materials and methods useful in phototherapy. In particular, the topical biophotonic materials of the present disclosure include a cohesive matrix, and at least one chromophore which can absorb and emit light from within the topical biophotonic material, wherein the topical biophotonic material is elastic. The topical biophotonic materials and the methods of the present disclosure are useful for promoting wound healing and skin rejuvenation, as well as treating acne and various other skin disorders.

The present invention relates to a composition for lightening keratin fibres, comprising at least one chemical oxidizing agent, at least one (bi)carbonate, at least one silicate, at least one alcohol and at least one compound chosen from organic acids, amphoteric or zwitterionic compounds, esters and/or amides and/or imines, organic amines, alkanes and/or alkenes and/or ethers and mixtures thereof, and also to a process for lightening keratin fibres using said composition.

The present invention relates to a composition for lightening keratin fibres, comprising at least one chemical oxidizing agent, at least one (bi)carbonate, at least one silicate, at least one organic amine and at least one compound chosen from alcohols, amphoteric or zwitterionic compounds, esters and/or amides and/or imines, organic acids, alkanes and/or alkenes and/or ethers and mixtures thereof, and also to a process for lightening keratin fibres using said composition.

The present disclosure relates to a plaque disclosing composition containing riboflavin 5-phosphate sodium, a method for disclosing a plaque, wherein the plaque is an acquired pellicle, and a method for collecting and analyzing an information about the amount and characteristics of dental plaque by analyzing the color and intensity of fluorescence emitted by riboflavin 5-phosphate sodium for effective treatment of dental plaque even at an early stage.

Provided is a novel cosmetic containing: an ultraviolet wavelength conversion substance and a drug.